Weaver Capital Management LLC Makes New Investment in UnitedHealth Group Incorporated $UNH

Posted by Francis Steltz on Oct 16th, 2026

Weaver Capital Management LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 3,375 shares of the healthcare conglomerate’s stock, valued at approximately $1,239,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Triasima Portfolio Management inc. purchased a new position in shares of UnitedHealth Group in the third quarter worth $2,384,000. Mystic Asset Management Inc. grew its holdings in shares of UnitedHealth Group by 2.2% during the third quarter. Mystic Asset Management Inc. now owns 7,964 shares of the healthcare conglomerate’s stock valued at $2,923,000 after buying an additional 170 shares during the last quarter. WealthPLAN Partners LLC increased its position in shares of UnitedHealth Group by 37.2% in the 3rd quarter. WealthPLAN Partners LLC now owns 3,560 shares of the healthcare conglomerate’s stock valued at $1,307,000 after acquiring an additional 966 shares during the period. Ninety One UK Ltd lifted its position in UnitedHealth Group by 14.8% during the 3rd quarter. Ninety One UK Ltd now owns 1,266,720 shares of the healthcare conglomerate’s stock worth $464,988,000 after acquiring an additional 163,350 shares during the period. Finally, Ninety One North America Inc. grew its stake in UnitedHealth Group by 24.8% during the 3rd quarter. Ninety One North America Inc. now owns 14,374 shares of the healthcare conglomerate’s stock valued at $5,276,000 after purchasing an additional 2,856 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.19% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Up 3.0%

Shares of UNH opened at $407.45 on Friday. The company has a market capitalization of $365.72 billion, a price-to-earnings ratio of 23.27, a PEG ratio of 1.43 and a beta of 0.60. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The stock’s 50-day moving average price is $387.17 and its 200-day moving average price is $384.52. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same period last year, the business earned $2.59 earnings per share. UnitedHealth Group’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 20.66 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: Q3 earnings beat expectations: UnitedHealth reported adjusted EPS of $4.69 versus the $4.14 consensus estimate and revenue of $112.7 billion versus $111.31 billion expected. Revenue was roughly flat year over year, but profitability improved significantly. UnitedHealth Stock Moves Higher: What’s Going On?
Positive Sentiment: Higher earnings outlook: Management raised its 2026 adjusted earnings forecast to at least $20.50 per share, above its previous $19.50–$20.00 range. The guidance increase was the primary catalyst for the stock’s upward move. UnitedHealth Group gains after Q3 beat and higher 2026 outlook
Positive Sentiment: Margin recovery signals: The medical care ratio improved to 88.4%, while Optum generated $3.7 billion in earnings. Analysts also cited pricing discipline, benefit changes, care-delivery improvements and AI initiatives as potential supports for stronger 2027 growth. UNH Q3 Deep Dive: Margin Recovery and AI Initiatives Shape 2027 Outlook
Positive Sentiment: Constructive analyst views: Goldman Sachs reportedly raised its price target to $506, while Piper Sandler maintained an overweight rating and lifted its target to $504. Mizuho also continues to view UNH as a top healthcare pick. Goldman Sachs raises UNH target price to $506
Neutral Sentiment: Defensive appeal: UnitedHealth is being highlighted as a low-beta healthcare stock that could benefit from investor demand for defensive companies if inflation and energy costs remain elevated. 3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
Negative Sentiment: Growth risks remain: Analysts flagged shrinking membership, pressure from commercial medical costs and Medicaid, and uncertainty surrounding Medicare participation. TD Cowen reaffirmed a hold rating with a $402 target, while other firms reduced targets despite maintaining generally positive ratings. UnitedHealth Beats on Earnings, But Investors Question Growth Path

Analyst Ratings Changes

A number of research analysts have recently weighed in on UNH shares. UBS Group reissued an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday. Evercore upped their target price on UnitedHealth Group from $400.00 to $480.00 and gave the company an “outperform” rating in a research report on Tuesday, July 7th. KeyCorp reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Finally, Jefferies Financial Group increased their price objective on shares of UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a research note on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $461.48.

Read Our Latest Stock Analysis on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.